Scientists track sedative in transplant patients
NCT ID NCT07045467
Summary
This study aims to understand how a sedative drug called remimazolam works in the bodies of people receiving a kidney transplant. Researchers will give the drug to 30 participants during their transplant surgery and take blood samples to measure drug levels. They will also monitor how deeply sedated the participants are to see if the drug provides safe and predictable sleep during the operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong First Medical University Hospital
RECRUITINGJinan, Shangdong, 250014, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.